Close Menu

NEW YORK – Belgian diagnostics firm miDiagnostics announced on Thursday the completion of a €14 million ($15.3 million) financing round to accelerate the development of its technology.

Investors in the round include existing shareholders as well as individual investors Rudi Pauwels, founder and former CEO of Biocartis, and Urbain Vandeurzen, founder and chairman of Smile Invest and former co-founder, chairman and CEO of LMS International.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.